投资者增加了Illumina的股份, 超过了预期的收益, Investors boost stakes in Illumina, which beat earnings estimates, driving its stock up.

一些机构投资者增加了对生命科学公司Illumina公司的股权。 Several institutional investors have increased their stakes in Illumina, Inc., a life sciences company. Vinva投资管理有限公司购买了6 600个股票,而洛克菲勒资本管理有限公司和马韦里克资本有限公司等其他公司则调整了其股份。 Vinva Investment Management Ltd bought 6,600 shares, while others like Rockefeller Capital Management and Maverick Capital Ltd adjusted their holdings. Illumina最近报告的收入为每股1.14美元,殴打估计数为0.26美元。 Illumina recently reported earnings of $1.14 per share, beating estimates by $0.26. 分析师给予正面评价,协商一致的“机动购买”和目标价格为164.00美元。 Analysts have given positive ratings, with a consensus "Moderate Buy" and a target price of $164.00.